The global gel documentation systems market is expected to reach USD 1,596.92 million by 2021,
growing at a CAGR of almost 7%. This research report titled ‘Global
Gel Documentation Systems Market 2017-2021’ provides an in-depth analysis
of the market in terms of revenue and emerging market trends. This market
research report also includes up to date analysis and forecasts for various
market segments and all geographical regions.
The global gel documentation systems market is expected to grow
at a moderate speed during the forecast period as there is a surge in use of
molecular biology techniques in clinical practice along with the shift of the
healthcare industry towards automation. Gel documentation systems have advanced
as earlier technicians used instant cameras to detect gel bands. This method
was prone to contamination, and hence, the accuracy of results was very low.
Dynamic range, faster gel exposure, and higher efficiency are some of the
crucial factors that helped gel documentation systems replace the traditional
approaches.
This report is available at a USD 1,000 discount for a limited
time only: View market snapshot before
purchasing
Buy 1 Technavio report and get the second for 50% off.
Buy 2 Technavio reports and get the third for free.
Technavio’s research analysts categorize the global gel documentation
systems market into the following segments by end-user. They are:
·
Hospitals and diagnostic centers
·
Pharma and biotech companies
·
Academic and research institutes
Hospitals and diagnostic centers
Gel documentation systems are utilized in the routine hospital
and diagnostic settings for the diagnosis of infectious diseases such as flu,
HIV/AIDS, and H1N1 flu. Due to an increasing global prevalence of various
diseases, hospitals and diagnostic centers receive large volumes of patient
samples every day and hence there is a need for gel documentation systems for
accurate diagnosis and treatment planning for patients.
According to Krishna Venkataramani, a lead lab equipment research
analyst from Technavio, “Factors such as rising incidences of infectious
diseases coupled with persistent product modifications contribute to the demand
for gel documentation systems. Also, the enhanced discovery of biomarkers and
introduction of novel drugs leading to increased therapeutic drug monitoring
will further augment the need for these assays.”
Pharma and biotech companies
Gel documentation systems assist in DNA and protein analysis and
detection, which can help pharma and biotech companies to develop innovative
treatments in new research areas and also help them develop personalized
medicine.
“Pharma and biotech companies put a considerable amount of
focus on R&D and look for methods for completing their projects in the
pipeline in a faster and efficient manner. Product innovations in gel
documentation such as high precision cameras, which give out better results
than conventional systems can help pharma companies achieve this goal,”
says Krishna.
Academic and research institutes
Academic and research institutes are increasingly using gel
documentation systems as they are the basic instruments, which are used in
every process and experiment to understand and develop novel approaches to
genetic diagnosis, molecular diagnosis, molecular forensics. multiparametric
molecular diagnostics, cancer progression and diagnostics, genomics in
infectious diseases, genetic testing and mass spectrometry– based quantitative
metabolomics.
Molecular forensics offer a comprehensive coverage of the
increasingly important role that molecular analysis plays in forensic science.
Variations in DNA sequences results in genetic differences amongst people,
which can be applied to investigate and establish facts in criminal, civil, and
administrative hearings.
The top vendors highlighted by Technavio’s research analysts in
this report are:
·
Bio-Rad
·
GE Healthcare
·
Thermo Fisher Scientific
No comments:
Post a Comment